SEMELCEF 200 mg tablets for dogs and cats
SEMELCEF 200 mg tablets for dogs and cats
Authorised
- Cefadroxil monohydrate
Product identification
Medicine name:
SEMELCEF 200 mg tablets for dogs and cats
Semelcef 200 mg Tablet
Semelcef 200 mg Comprimé
Semelcef 200 mg Tablette
Active substance:
- Cefadroxil monohydrate
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Cefadroxil monohydrate210.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01DB05
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- box containing 10 blisters of 10 tablets (100 tablets)
- box containing 1 blister of 10 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V545306
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0304/001
Concerned member states:
-
Austria
-
Belgium
-
Croatia
-
Cyprus
-
Czechia
-
Estonia
-
Greece
-
Hungary
-
Ireland
-
Poland
-
Portugal
-
Slovakia
-
Slovenia
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
eu-PUAR-esv0304001-dcp-semelcef-200-mg-tablets-for-dogs-and-cats-en.pdf
English (PDF)
Download Published on: 25/12/2023
How useful was this page?: